Product Description
CYCLIZINE (SYE kli zeen) is an antihistamine. It is used to prevent and to treat the nausea, vomiting, or dizziness of motion sickness. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. (Sourced from: https://my.clevelandclinic.org/health/drugs/19014-cyclizine-oral-tablets)
Mechanisms of Action: H1 Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Australia | Bangladesh | Canada | Denmark | Egypt | Finland | Germany | Greece | Ireland | Italy | Malta | New Zealand | Norway | Pakistan | Singapore | South Africa | Taiwan | United Arab Emirates | United Kingdom | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|